
In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.
Should malingering be considered more likely than factitious disorder when a patient exhibits pseudologia fantastica? What condition persists for longer than 3 months, accompanies a disease process, and is associated with a bodily injury that has not resolved over time? These questions and more in this interactive quiz.




